SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who started this subject7/31/2002 8:28:56 PM
From: scaram(o)uche  Read Replies (1) of 2243
 
Message 17820673

"taxable on vesting"

That's the key. Make employees pay for the options as they vest. Make them share the pain in the event of failure, to access the potential upside.

The history of repricing at XOMA is a sickening example of abuse.

For years, biotech millionaires have been walking, without having created a diagnostic or therapeutic. That attitude is what created the Waksals of the world. The attitude? "All one need do is keep a biotech alive, and you will be rich". It's the entire reason to be for the bait and switch companies of the world.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext